Meusinvest (Noshaq)

Le Fourgon is a provider of home delivery services specializing in a variety of drinks, including milk, water, beer, wine, fruit juice, and sodas. The company employs a system of recyclable bins for its products, facilitating an eco-friendly approach to consumption. Upon delivery of new orders, Le Fourgon also collects empty crates and bottles, ensuring a streamlined and sustainable process for consumers. By offering free daytime delivery, Le Fourgon enhances convenience for customers while promoting an environmentally responsible delivery system.

TrustUp is a platform designed to connect homeowners with verified home improvement contractors. It operates a marketplace that facilitates the search for and hiring of reliable professionals for various construction and renovation services. By ensuring a guarantee of quality work, TrustUp enables customers to access consistent and effective professional services for their home projects. The platform aims to streamline the process of finding suitable contractors, ultimately enhancing the home improvement experience for homeowners.

Veoware specializes in satellite imagery services. It develops space-based systems for on-demand access to Earth imagery, enhancing data collection capabilities through advanced actuator technology.

Brenus Pharma develops allogeneic cell-based immunotherapies for solid tumors. The company creates allogeneic cell vaccines to empower immune cells in vivo to recognize and attack cancer, by mimicking tumor properties and increasing visibility to the immune system. Its platform aims to educate the immune system to anticipate relapse mechanisms by stimulating selected tumor cell lines, enabling clinicians to induce responses during chemotherapy or radiotherapy. The approach seeks to prevent cancer resistance to treatment and improve durability of responses across solid tumors.

Get Your Way develops augmented reality glasses designed to enhance operational efficiency across industries. Their products reduce paperwork, speed up tasks, track product journeys, and provide hands-free digital workflows, improving accuracy and ensuring compliance.

Hedera-22 specializes in the discovery of natural products using proprietary bioinformatics technologies. It combines predictive algorithms, genome mining, metabolomics, and DNA synthesis to identify bioactive molecules with antifungal and herbicidal properties. The company maintains a molecular library for licensing, supporting agricultural and pharmaceutical stakeholders seeking environmentally focused applications.

Founded in 2014 and based in Ecublens, Switzerland, SamanTree Medical develops digital microscopy systems using micro-optics for research, diagnostics, and surgeries. Its flagship product is a surgical digital microscope that enables real-time visualization of living tissue structure, enhancing surgical decision-making and reducing re-operation rates.

Myocene is a Belgian sports technology company specializing in the development of innovative devices designed to measure muscle fatigue and performance. Their patented algorithms enable athletes to track their endurance and stamina effortlessly.

Novobiom is a company focused on bioremediation, specifically designed to address persistent and pervasive pollutants in contaminated soil. Utilizing innovative mycoremediation technology, which employs mushrooms, Novobiom offers tailored solutions for soil pollution, effectively treating hazardous waste while promoting sustainability. In addition to its remediation services, the company provides consultation to enhance sustainability awareness and innovation, guiding industries in achieving their strategic environmental goals through biomimetic approaches.

EXO Biologics is a biotech company developing biopharmaceuticals using extracellular vesicles, specifically exosomes, to create novel therapeutic candidates aimed at conditions such as dysplasia and Crohn's disease. Its exosome-based therapies are designed to facilitate intercellular communication by transferring proteins, lipids, and genetic material and signaling through cell surface or endosomal receptors. The company emphasizes large-scale, cost-effective, and consistent production to enable affordable and accessible therapies for patients with unmet medical needs.

CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in the development of a proprietary cryotherapy system aimed at treating coronary artery disease, a major cause of heart attacks. The company focuses on demonstrating the clinical benefits and ensuring the safety and efficacy of cryoenergy in the cardiovascular system. Its novel catheter system utilizes cryo energy to treat and prevent heart attacks, offering a promising approach to addressing the challenges posed by diseased coronary arteries. Through its early-stage commercialization efforts, CryoTherapeutics aims to enhance treatment options for heart surgeons and improve patient outcomes in cardiovascular health.

Hephaistos Pharma is a biotechnology company developing an immunotherapy platform aimed at producing advanced oncology treatments. Its platform enhances commercialized antibodies by stimulating the immune system, turning 'cold' tumors into targets for immune response.

Raw Stadia is a technology company specializing in interactive sports surface solutions and aerial inspection systems for confined environments. The company develops platforms that enable surface-level player interactions in sports contexts and operates compact dual-rotor aerial systems equipped for indoor inspections. The inspection platform includes extended-operation time, integrated environmental mapping, robust lighting for low-visibility areas, and sensors for detecting hazardous gases, supporting safer and more effective inspections across industrial sectors.

Samabriva is a biotechnology company that specializes in developing innovative platforms for producing biomolecules from plant materials. Its flagship platform, RHIZOBRIVA™, enables the creation of biomolecules suitable for various industries, including pharmaceuticals, cosmetics, agrochemicals, and food. Additionally, Samabriva has established an independent business unit, NANOBRIVA™, which focuses on developing orphan drugs specifically for lysosomal storage disorders. This unit is dedicated to creating proprietary lysosomal enzymes that exhibit enhanced bioavailability, utilizing a unique technology compatible with diverse production systems, including mammalian cell cultures and bacteria. By leveraging these advanced platforms, Samabriva aims to address unmet medical needs and improve treatment options for patients with rare diseases.

Amyl Therapeutics is a preclinical biotech company developing therapeutics targeting various amyloid fibrils, including those implicated in systemic amyloidosis and neurodegenerative diseases like Alzheimer's and Parkinson's.

Founded in 2010, Ampacimon specializes in dynamic line rating systems for transmission and distribution grid operators worldwide. Its solutions include ADR View, ADR Sense, ADR Operate, ADR Trend, and ADR Horizon, enabling operators to forecast congestion problems and address them through cost-effective reconfiguration actions.

RISORCE fills a need in Belgium for local solutions for processing tire waste while remaining dedicated to a circular economy strategy. We provide a regionally-based, technologically and environmentally sound solution.

Toopi Organics is a biotechnology company based in Langon, France, established in 2019. It develops microbiological and agricultural technologies to transform human urine into fertilizers and biostimulants for agriculture. The company collects and upcycles human urine, depollutes and enriches it with microorganisms to provide natural, economical, and efficient alternatives to chemical fertilizers. Its products include Arbop and Vitip, which support plant growth and crop health, offering farming communities an environmentally conscious option for nutrient supply.

Axithra specializes in therapeutic medication monitoring, specifically focusing on measuring beta-lactam antibiotic concentrations in blood. Its proprietary platform enables personalized treatments by accurately determining drug concentrations, optimizing patient care.

Purecontrol is a developer of industrial automation systems that leverage artificial intelligence to facilitate continuous improvement in complex installations. The company's platform employs advanced AI algorithms to analyze equipment operations, enabling real-time and predictive control. By enhancing industrial performance and optimizing energy efficiency, Purecontrol helps organizations improve process reliability while simultaneously reducing energy costs and their carbon footprint. Additionally, the platform supports predictive maintenance, allowing companies to anticipate needs and minimize downtime, thereby streamlining operations effectively.

Myocene is a Belgian sports technology company specializing in the development of innovative devices designed to measure muscle fatigue and performance. Their patented algorithms enable athletes to track their endurance and stamina effortlessly.

Myocene is a Belgian sports technology company specializing in the development of innovative devices designed to measure muscle fatigue and performance. Their patented algorithms enable athletes to track their endurance and stamina effortlessly.

IVEX is a technology company specializing in the development of tools and software for the testing and validation of advanced driver-assistance systems (ADAS) and autonomous driving (AD) vehicles. Originating from the University of Leuven, IVEX has assembled a diverse team from over ten countries and has established partnerships with prominent industry players, including Siemens. The company focuses on enhancing the efficiency of engineers who analyze extensive driving data generated by AD/ADAS systems. IVEX offers a cloud-based suite of testing and validation tools, alongside an onboard real-time safety checker, which can function independently or in tandem. Its software solutions enable the identification and categorization of driving scenarios, the creation of digital representations for simulation, and the analysis of large datasets with reduced computational demands. By prioritizing safety and performance, IVEX positions itself as a critical player in the evolving landscape of automated vehicle technology.

DeuterOncology is a preclinical-stage biotechnology company dedicated to advancing cancer treatment through innovative therapies. The firm is developing a first-in-class dual MET and RAS pathway inhibitor, which is currently undergoing preclinical investigation. This lead compound aims to serve as a targeted therapy primarily for lung cancer, while also holding promise for broader applications in oncology when used in combination with standard of care and other targeted agents. By focusing on optimizing treatment outcomes, DeuterOncology seeks to empower medical professionals in their efforts to effectively combat cancer.

Algama is a pioneering food-tech company that harnesses the power of algae to create sustainable, nutritious food solutions. Founded in 2013, Algama aims to feed the world's growing population while preserving the planet by developing microalgae-based ingredients for various applications, with a focus on egg substitutes for bakery products.

MyCellHub, originated from KU Leuven, provides a regulatory-compliant software platform for biotherapeutics manufacturing that digitalizes cell production workflows. It offers a bio-manufacturing execution system and data-management analytics SaaS that captures data in real time, integrates with ERP systems, and maintains automated batch records and a real-time audit trail to support regulated lab and cleanroom environments. The platform aims to improve efficiency of cell culture processes and enable optimization of advanced therapy production through data analytics and actionable insights.

Intressa Vascular specializes in cardiovascular solutions, focusing on treating aortic dissections. They offer endovascular treatments using their proprietary braiding technology platform and procedure planning services to enhance patient care.

Graftys is an early-stage company based in Aix-en-Provence, France, focused on advanced bone biologics. It develops synthetic calcium phosphate bone graft substitutes that are fully injectable and designed for reconstructive orthopedic surgery. The company’s products target specific clinical applications, enabling standard options for bone reconstruction and trauma procedures. Through its biomaterials, Graftys aims to provide safe, predictable options for surgeons seeking injectable bone graft substitutes to support healing in challenging skeletal defects.

Maana Electric specializes in space technology with a focus on sustainable energy. It aims to become the first solar system utility company, developing technologies that have immediate applications on Earth and potential uses in space.

Eclo is an urban farming company that specializes in producing exotic mushrooms by utilizing waste materials, specifically spent beer grain. By recycling this byproduct, Eclo not only contributes to sustainable practices but also provides customers with organic mushrooms and baby herbs. The company's focus on innovative waste management in agriculture highlights its commitment to environmental responsibility while meeting the growing demand for high-quality, organic produce.

Aerospacelab is a Belgian company founded in 2017 that designs, builds, and operates small satellites equipped with high‑resolution optical sensors. Its platform captures multiple images of the same area, enabling frequent monitoring of land, infrastructure, and environmental changes. The company integrates artificial intelligence and machine learning to automate tasks such as surveying, data processing, and analysis, allowing clients to quickly interpret large volumes of imagery. Headquartered near Brussels, Aerospacelab serves customers in agriculture, forestry, urban planning, and disaster response, providing actionable insights from satellite data.

IONNYK is a pioneering platform specializing in art photography. It offers digital frames featuring monochrome photographs, produced using microscopic ink capsules for a paper-like effect without backlighting. The frames are wireless and encased in aluminum with museum-grade glass, showcasing curated artwork selections accessible via an app.

VistaCare is a French company specializing in innovative medical devices for treating acute and chronic wounds. It develops, manufactures, and distributes products designed to enhance patient quality of life and simplify caregiver routines by reducing treatment times and hospital stays.

EyeD Pharma SA is a pharmaceutical company based in Liège, Belgium, specializing in the development and commercialization of innovative drug products for ophthalmology. The company focuses primarily on the treatment of glaucoma, a condition historically managed with daily eye drops. EyeD Pharma aims to enhance the quality of life for patients by reducing the side effects associated with traditional therapies. In collaboration with ophthalmologists, the company offers new treatment options and surgical products that improve clinical practices and provide therapeutic assistance that is currently lacking in the market. Through its efforts, EyeD Pharma seeks to advance the standard of care in ophthalmology.

PDC*line Pharma is a French-Belgium clinical-stage biotech company developing active immunotherapies for cancer using its proprietary Plasmacytoid Dendritic Cell line, PDC*line. These therapies aim to stimulate potent and scalable antitumor immune responses.

Amyl Therapeutics is a preclinical biotech company developing therapeutics targeting various amyloid fibrils, including those implicated in systemic amyloidosis and neurodegenerative diseases like Alzheimer's and Parkinson's.

Gabi SmartCare is a medical technology startup developing predictive at-home monitoring solutions for early diagnostics and daily management of chronic respiratory diseases in children aged zero to twelve. Its platform monitors and diagnoses respiratory issues, enabling healthcare professionals to provide optimal care.

Imcyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, specializing in innovative immunotherapeutic solutions aimed at treating severe chronic autoimmune diseases. Founded in 2010, Imcyse is pioneering a unique technology platform that employs Imotopes™, specifically modified peptides that target immune cells responsible for organ damage. This approach facilitates the generation of cytolytic CD4 T-cells, which selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, thereby addressing diseases with limited treatment options. The company has shown proof of concept across various indications and has completed its initial clinical trial for type 1 diabetes, yielding promising outcomes. In addition to type 1 diabetes, Imcyse is actively developing a pipeline of therapies for multiple autoimmune diseases, aiming to provide effective treatment while preserving overall immune defense.

Founded in 2011, GeneQuine Biotherapeutics specializes in designing and developing gene therapies for clients. Its primary focus is on treating osteoarthritis through innovative products such as GQ-201, GQ-202, and GQ-203.

ABSCINT engages in the development of radiolabelled single-domain antibodies for whole-body molecular imaging applications. Molecular imaging is used for the diagnosis of disease, the molecular characterization of a disease, monitoring treatment response, and the detection of disease recurrence.

Miracor Medical develops cardiovascular medical devices, notably the PiCSO impulse system, a pressure‑controlled intermittent coronary sinus occlusion device designed to improve microvascular perfusion and cardiac function after acute myocardial infarction. The system supports treatment of myocardial infarction and can be used in surgical settings such as coronary artery bypass grafting to facilitate perfusion improvements. Founded in 2008, the company is based in Awans, Belgium, with a presence in Vienna, Austria.

Founded in 2010, Ampacimon specializes in dynamic line rating systems for transmission and distribution grid operators worldwide. Its solutions include ADR View, ADR Sense, ADR Operate, ADR Trend, and ADR Horizon, enabling operators to forecast congestion problems and address them through cost-effective reconfiguration actions.

ExeVir Bio BV is a Belgian biotechnology company founded in 2020 and headquartered in Zwijnaarde. The company specializes in developing single-domain antibody-based therapies aimed at preventing viral infections. Utilizing a llama-derived antibody technology platform, ExeVir Bio focuses on creating robust antiviral treatments, particularly targeting coronaviruses. One of its key products, VHH72-FC, binds to a conserved region of the SARS-CoV-2 spike protein, which is crucial for the virus's entry into human cells. The company has established a rapid response platform for antivirals, allowing for a quick adaptation to emerging health threats through a streamlined process for generating drug candidates. Their protein-based therapeutics are designed to be stable, cost-effective, and accessible on a global scale, addressing significant public health challenges posed by viral infections.

E-peas SA is a Belgian company established in 2014, specializing in the design and manufacturing of electronic systems that provide energy autonomy for Internet of Things (IoT) applications. The company develops innovative energy harvesting solutions that enable devices to draw energy from various ambient sources, including solar, thermal, vibration, and radiofrequency. E-peas produces energy harvesting power management integrated circuits (PMICs) and microcontrollers that enhance the performance and longevity of IoT devices by either extending battery life or eliminating the need for batteries altogether. Their technology caters to a wide range of sectors, including home automation, healthcare, retail, and agriculture, thereby facilitating the creation of smarter and more energy-efficient connected devices. Headquartered in Mont-Saint-Guibert, Belgium, E-peas aims to transform the landscape of portable energy solutions.

Bloomlife is a pioneering company in maternal health, leveraging connected devices and cloud-based data analytics to enhance access to care for expectant mothers. Its innovative solution enables obstetricians to more efficiently screen and manage pregnancy complications, empowering women and reducing geographical barriers.

Founded in 2013, Hyloris Pharmaceuticals specializes in reformulating established pharmaceuticals to create innovative products that offer advantages over existing alternatives. The company focuses on cardiovascular treatments and other therapeutic areas, with a portfolio including Sotalol IV for atrial fibrillation.

IVEX is a technology company specializing in the development of tools and software for the testing and validation of advanced driver-assistance systems (ADAS) and autonomous driving (AD) vehicles. Originating from the University of Leuven, IVEX has assembled a diverse team from over ten countries and has established partnerships with prominent industry players, including Siemens. The company focuses on enhancing the efficiency of engineers who analyze extensive driving data generated by AD/ADAS systems. IVEX offers a cloud-based suite of testing and validation tools, alongside an onboard real-time safety checker, which can function independently or in tandem. Its software solutions enable the identification and categorization of driving scenarios, the creation of digital representations for simulation, and the analysis of large datasets with reduced computational demands. By prioritizing safety and performance, IVEX positions itself as a critical player in the evolving landscape of automated vehicle technology.

Odoo is an open-source platform that offers a comprehensive suite of integrated business applications tailored for various operational needs of companies. Its software encompasses tools for customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. The applications are designed to function cohesively, enabling seamless workflows across different departments. By facilitating automation and tracking capabilities, Odoo empowers businesses to manage their operations efficiently from any device, making it a versatile solution for organizations of all sizes.

MyCellHub, originated from KU Leuven, provides a regulatory-compliant software platform for biotherapeutics manufacturing that digitalizes cell production workflows. It offers a bio-manufacturing execution system and data-management analytics SaaS that captures data in real time, integrates with ERP systems, and maintains automated batch records and a real-time audit trail to support regulated lab and cleanroom environments. The platform aims to improve efficiency of cell culture processes and enable optimization of advanced therapy production through data analytics and actionable insights.

Osivax develops immunotherapy vaccines designed to enhance the body's immune response against infectious diseases. Their vaccines aim to expedite uptake into dendritic cells and increase immunogenicity of natural proteins, triggering a more effective immune response, including CD8 T cell activation. This enables medical practitioners to treat patients with conditions such as cancer, influenza, malaria, and other infectious diseases.

CryoTherapeutics GmbH, founded in 2009 and based in Cologne, Germany, specializes in the development of a proprietary cryotherapy system aimed at treating coronary artery disease, a major cause of heart attacks. The company focuses on demonstrating the clinical benefits and ensuring the safety and efficacy of cryoenergy in the cardiovascular system. Its novel catheter system utilizes cryo energy to treat and prevent heart attacks, offering a promising approach to addressing the challenges posed by diseased coronary arteries. Through its early-stage commercialization efforts, CryoTherapeutics aims to enhance treatment options for heart surgeons and improve patient outcomes in cardiovascular health.

Imcyse SA is a clinical-stage biopharmaceutical company based in Liège, Belgium, specializing in innovative immunotherapeutic solutions aimed at treating severe chronic autoimmune diseases. Founded in 2010, Imcyse is pioneering a unique technology platform that employs Imotopes™, specifically modified peptides that target immune cells responsible for organ damage. This approach facilitates the generation of cytolytic CD4 T-cells, which selectively eliminate antigen-presenting cells and autoantigen-specific lymphocytes, thereby addressing diseases with limited treatment options. The company has shown proof of concept across various indications and has completed its initial clinical trial for type 1 diabetes, yielding promising outcomes. In addition to type 1 diabetes, Imcyse is actively developing a pipeline of therapies for multiple autoimmune diseases, aiming to provide effective treatment while preserving overall immune defense.

Graftys is an early-stage company based in Aix-en-Provence, France, focused on advanced bone biologics. It develops synthetic calcium phosphate bone graft substitutes that are fully injectable and designed for reconstructive orthopedic surgery. The company’s products target specific clinical applications, enabling standard options for bone reconstruction and trauma procedures. Through its biomaterials, Graftys aims to provide safe, predictable options for surgeons seeking injectable bone graft substitutes to support healing in challenging skeletal defects.

Phasya specializes in developing advanced eye tracking technologies for detecting drowsiness and measuring eye movements. The company utilizes high-speed cameras integrated into glasses to capture ocular images, enabling automatic, objective, and real-time assessments of drowsiness and various ocular parameters. Phasya's solutions extend beyond drowsiness detection to include the measurement of physiological and cognitive states such as stress, attention, cognitive load, and mind wandering. These technologies find applications in safety, medical diagnosis, and research, with a particular focus on driver monitoring. By analyzing eye movements and physiological responses, Phasya aims to enhance understanding of brain activity and gaze behavior, thereby improving task performance and decision-making capabilities.

Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires

Miracor Medical develops cardiovascular medical devices, notably the PiCSO impulse system, a pressure‑controlled intermittent coronary sinus occlusion device designed to improve microvascular perfusion and cardiac function after acute myocardial infarction. The system supports treatment of myocardial infarction and can be used in surgical settings such as coronary artery bypass grafting to facilitate perfusion improvements. Founded in 2008, the company is based in Awans, Belgium, with a presence in Vienna, Austria.

Onoff Telecom is a company that focuses on enhancing communication for both private and business customers. It has developed a mobile application that allows users to integrate multiple phone numbers into a single platform. This application enables functionalities such as making calls, sending custom voice messages, and exchanging texts, photos, videos, and audio recordings internationally. Additionally, Onoff's service includes cloud storage for contacts and the ability to manage and hide phone numbers, ensuring privacy. Users can organize their communications efficiently by sorting messages based on different numbers, thus revolutionizing the way individuals and businesses manage their communication needs.

Convert Pharmaceuticals SA is a biotech company based in Saint-Gilles, Belgium, founded in 2017. The company focuses on the development of hypoxia-activated cytotoxic small molecules aimed at treating cancer. As a clinical stage enterprise, Convert Pharmaceuticals is building a proprietary drug pipeline that leverages specific factors within the tumor microenvironment to enhance therapeutic outcomes. Its lead product is a hypoxia-activated prodrug designed to overcome the therapeutic challenges posed by hypoxia, which can lead to resistance against conventional cancer treatments. By integrating proprietary insights into the tumor microenvironment with expertise in drug and biomarker development, Convert Pharmaceuticals aims to create effective and well-tolerated therapies for cancer patients.

Soundbops is a company focused on enhancing music education for young children through innovative musical building blocks. These blocks feature colored buttons that produce eight distinct instrument tones, allowing for endless combinations and the creation of chords and new songs. By providing an engaging and educational tool, Soundbops aims to foster a love for music in early learners. The company is in the process of launching and is actively seeking advisers and co-founders with expertise in marketing to support its efforts.

Miracor Medical develops cardiovascular medical devices, notably the PiCSO impulse system, a pressure‑controlled intermittent coronary sinus occlusion device designed to improve microvascular perfusion and cardiac function after acute myocardial infarction. The system supports treatment of myocardial infarction and can be used in surgical settings such as coronary artery bypass grafting to facilitate perfusion improvements. Founded in 2008, the company is based in Awans, Belgium, with a presence in Vienna, Austria.

Aerosint is a Belgian company founded in 2016, dedicated to the research and development of innovative additive manufacturing processes, particularly in the field of 3D printing. The company has developed a unique selective powder recoating technology that allows for the deposition of fine powder layers composed of multiple materials. This technology enables multimaterial 3D printing by sintering different powders within each layer, effectively achieving a zero-waste process for high-performance polymers. Aerosint's advancements not only enhance the efficiency of 3D printing but also reduce costs, making it a significant player in the additive manufacturing landscape.

TConcept offers you the perfect brewing appliance, Teh®. This unique device will be launched on the market this year and will be able to provide extraordinary premium tea taste and olfactory sensation by respecting the infusion procedures. The ultimate tea experience. Fully automatic, their appliance provide to the tea an appropriate infusion vessel to enable tea leaves deliver their precious oils and ingredients. In its system, T-Concept has designed and developed a unique brewing apparatus where the internal part of the chamber (called the brewing vessel) is connected to the tea cartridge. Both are tightly sealed. The water is poured in the vessel and (being the cartridge sealed to it) gently flows into the capsule and prevent a thermal shock to raw material. Their brewing appliance has many capacities, including a recognition system by colors which allows him to select the appropriate temperature for each type of tea (each one of them possess her own color). It's also capable of performing an automatic rinsing and a capsule ejection, can display the brewing time, the temperature and the progress percentage for each brewing. And he can do it all with a contemporary design, giving you the feeling of meeting a real tea expert. Their capsules, with their special and transparent packaging, allow you too see the tea, his color and his ingredients and even smell all of his aromas and to make the perfect choice.

Bloomlife is a pioneering company in maternal health, leveraging connected devices and cloud-based data analytics to enhance access to care for expectant mothers. Its innovative solution enables obstetricians to more efficiently screen and manage pregnancy complications, empowering women and reducing geographical barriers.

Preesale is a mobile-based ticket management application founded in 2015 and based in Liege, Belgium. It enables event organizers to efficiently sell tickets and access cash flows prior to their events, distinguishing it from traditional ticketing platforms. Preesale's application integrates seamlessly with Facebook, allowing users to create targeted ticket sales in under five minutes. The platform enhances revenue opportunities for organizers by providing tools to track sales analytics and communicate with attendees through SMS. Additionally, it offers a streamlined entry process, allowing ticket scanning via smartphones with free applications for both iPhone and Android. Preesale's mission is to improve visibility and accessibility to events, making it a valuable resource for event organizers seeking to optimize their ticketing processes.

Founded in Paris, France in 2010, YouScribe is a community platform that facilitates the sharing and selling of digital publications. It offers an online space for users to discuss and discover reading materials, build personal digital libraries, and publish writings or documents for wider visibility.

Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.

Aldento is a manufacturer of hand-made pasta made from edible insect flour with the goal of improving both nutritional value and environmental value. The food items produced by the company are prepared with insect flour, integrated grains, and nuts. They provide consumers with a fine dining option that is quick and simple to make, easy to incorporate into daily life, and environmentally friendly, allowing them to switch up their regular meals and use them in place of meat and fish.

Herrmutt Lobby is a collective that combines the talents of musicians, handymen, and programmers to create innovative hardware and software solutions. The organization focuses on developing a platform that fosters collaboration among musicians from diverse backgrounds. Its offerings include software, controllers, and applications designed to enhance live performances, allowing musicians to express their creativity spontaneously. The platform features a multitouch and evolving graphic interface, enabling users to interact with music by swiping and tapping on colored objects, thus facilitating an immersive and dynamic musical experience.

Student & Go is THE new professional social network for students and employers which aims to help students and fresh graduates thrive in a student job (summer jobs, internships, first jobs) in relation to their studies, while building their professional network. The place to be for students, fresh graduates and for companies : www.studentandgo.com

2 Observe is a company focused on observational research and the validation of innovative concepts within the biotechnology and private healthcare sectors. Established in 2010, it aims to address unmet needs in patient care by developing effective solutions that enhance quality of life. The company leverages the expertise of its founders, who come from diverse backgrounds in the medical community, research, and the life sciences industry. It specializes in patient monitoring technologies that provide continuous supervision of high-risk patients. These technologies alert healthcare providers in real-time, such as notifying nurses when a patient exits their bed or experiences complications related to respiratory failure, thereby ensuring that patients receive attentive and timely care.

Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.

XDC S.A. operates as a Pan-European digital cinema service company. It manages operations for the deployment of digital cinema systems in theatres; and prepares and delivers digital content, which is distributed in cinemas, as well as manufactures digital cinema products, including servers, theatre management systems, projections systems, and central libraries. The company's products include CineStore Systems, a suite of digital cinema solutions; The CineStore Solo G3, a hybrid digital cinema server that offer JPEG 2000 and MPEG-2 play-back capabilities; The CineStore Audi, a device, which provides digital to analogue conversion, external analogue audio source inputs, and signal isolation; The CineStore Plaza, a hardware and software suite that enables its users to manage a cinema multiplex from a single point, as well as 3D digital cinema. XDC S.A. also provides digital content lab for the whole production, post-production, and distribution chain, as well as to synchronize various sounds and subtitle versions on the master; key management and archiving; network operations centre, which includes a spare parts logistical strategy centre and a NOC equipment centre; and XDC Entertainment, a content delivery platform to alternative content distributors/providers. The company was founded in 2004 and is based in Liège, Belgium with additional offices in Belgium, Germany, Spain, and France.